Biosimilars play a critical role in lowering drug prices. Kaiser Permanente successfully uses biosimilars to improve affordability for our members. We are eager to share best practices and work with policymakers to help facilitate a more competitive market for biologic drugs in the United States.
The Kaiser Permanente Institute for Health Policy's experts Samantha Dupont, Krysten Joyce and Murray Ross join Kaiser Permanente's Senior Vice President of Government Relations, Tony Barrueta, to share their insights on the policy prescriptions needed to ensure prescribed drugs are…